DVA DaVita HealthCare Partners Inc
Company Analysis
Latest News
DaVita HealthCare Partners Inc Q3 2026 Earnings Preview: What Analysts Expect on October 29, 2026
DaVita is expected to report Q3 2026 revenue of $3.41 billion and earnings of $3.78 per share, with the stock currently trading at $165.45 against an average...
DaVita's 16% Plunge After an Earnings Beat Raises a Tough Question: Can a Dialysis Giant Grow When Its Patient Pool Won't?
DaVita Beats Expectations Then Loses 16% of Its Value — Is the Dialysis Business Running Out of Room to Grow? Shares of DaVita cratered 16% to $191.50 on...
🔴 DaVita HealthCare Partners is trading 4.37% down today after below-consensus 2026 EPS guidance
DaVita HealthCare Partners is trading 4.37% down at $180.45 after below-consensus 2026 EPS guidance following August 4 earnings. - Second-quarter revenue and...
🔴 DaVita HealthCare Partners is trading 16% down today on stagnant patient volumes and reiterated guidance
DaVita HealthCare Partners is trading 16% down at $191.50 after its latest quarterly update highlighted stagnant patient volumes and a lack of guidance...
🔴 DaVita HealthCare Partners is trading 4.5% down today as reiterated guidance and volume concerns offset Q2 earnings beat
DaVita HealthCare Partners is trading 4.5% down at $217.80 in pre-market, extending a two-day slide following its August 4, 2026 earnings release. • While the...
🔴 DaVita HealthCare Partners is trading 5.2% down today after a post-earnings reversal despite Q2 beats
DaVita HealthCare Partners is trading 5.2% down at $216.10 in after-hours trading following a sharp post-earnings reversal despite reporting...
DaVita's second quarter revenue of $3.55B and EPS of $4.02 beat estimates, driven by volume growth and cost management.
DaVita reported second quarter 2026 revenue of $3.554 billion and diluted earnings per share of $4.02, exceeding analyst estimates of $3.49 billion and $3.88,...
DaVita HealthCare Partners Inc Q2 2026 Earnings Preview: What Analysts Expect on August 04, 2026
Wall Street analysts expect DaVita to report Q2 2026 consensus revenue of $3.49 billion and earnings per share of $3.88, with the current stock price of...
🔴 DaVita HealthCare Partners is trading 4.3% down today amid broader market risk-off sentiment
DaVita HealthCare Partners is trading at $223.90 (4.3% down) as the stock tracks a broader market decline despite a lack of company-specific news. • The...
🔴 DaVita HealthCare Partners is trading 4.7% down today tracking broader risk-off sentiment
DaVita HealthCare Partners is trading at $224.52 (-4.70%) in pre-market, tracking a broader risk-off sentiment across global markets. • The move appears to be...
🔴 DaVita HealthCare Partners is trading 4.9% down today amid broader market weakness
DaVita HealthCare Partners is trading 4.9% down at $224.13 in after-hours trading, appearing to track broader market weakness and risk-off sentiment rather...
🔴 DVA is trading 6% down today as it pulls back from all-time highs amid broader risk-off sentiment
DVA is trading 6% down at $221 today, pulling back from recent all-time highs following its strong Q1 2026 results. • The move appears to be a normal...